-
Issues continue to dog the testing of Ebola drugs and vaccines
The fact that no “flexible and innovative protocol” exists for Ebola speaks to the complex practical and ethical issues that surround the use of untested drugs and vaccines in the midst of the explosive spread of a virus that kills more than half the people it infects.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Profit motive big hurdle for Ebola drugs, experts say
For nearly four decades, mention of the Ebola virus has evoked death and terror, yet a simple factor—money—has stood in the way of erasing the curse, experts say.
- Categories
- Education, Health Care
- Region
- Sub-Saharan Africa
-
A new challenge
The Gates Foundation’s Grand Challenges in Global Health programme is a decade old. How has it done, and what should it do in the future?
- Categories
- Education, Health Care
-
Pfenex And PATH Partner On Vaccines
Pfenex Inc., a clinical-stage biotechnology company engaged in the development of high-value biosimilar therapeutics and difficult to manufacture proteins, today announced the initiation of a multi-product research program with PATH.
- Categories
- Health Care
-
Vaccines targeting adults, teens best chance to eliminate TB
Targets to eliminate tuberculosis (TB) by 2050 are more likely to be met if new vaccines are developed for adults and adolescents rather than infants, according to a new research.
- Categories
- Health Care
-
Ebola Vaccine Trials May Give Placebo to Those at Risk
As global health officials rush to begin human trials of two promising Ebola vaccines in West African medical workers, a daunting question remains unanswered: Who gets the placebo injection?
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Plant-based vaccines challenge big pharma
The recent revelation that the Ebola drug ZMapp is produced in the leaves of tobacco plants captured global attention.
- Categories
- Health Care
-
GlaxoSmithKline, NewLink working to bring Ebola vaccines online: WHO
Both GlaxoSmithKline and NewLink Genetics are working to boost their capacity to make Ebola vaccines, with a goal of a "very significant increase in scale during the first half of 2015," the World Health Organization said on Wednesday.
- Categories
- Health Care